Eli Lilly’s GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory approval is planned for 2025.
New GLP-1 pill for weight loss may be closer to reality as drugmaker Eli Lilly says it will file for regulatory approval
Related Posts
-
White House briefly locked down after shooting near Washington Monument
An individual was shot by law enforcement Monday near the Washington Monument, the Secret Service…
-
Met Gala guests arrive on carpet in dramatic works of art
The Met Gala red carpet opened with stars in custom looks celebrating fashion as art…
-
Cruise ship outbreaks hit 23 in 2025, with norovirus the most common virus
While taking a cruise is generally safe, having a high concentration of people in a…
-
Met Gala 2026: Best red carpet looks for ‘Fashion is Art’ theme
Here are the looks from the Met Gala as stars arrive in fashion inspired by…
Leave a Reply